ZURICH/FRANKFURT (Reuters) – AstraZeneca’s should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker’s chief executive…
Home »
AstraZeneca pauses coronavirus vaccine trial as participant illness investigated
LONDON (Reuters) – AstraZeneca’s (AZN.L) suspension of global trials of its experimental coronavirus vaccine after an illness in a study subject in Britain has cast…
AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares
LONDON (Reuters) – AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker’s shares…
AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares
LONDON (Reuters) – AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker’s shares…
AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness
(Reuters) – AstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in…